Histogen Performance
| HSTODelisted Stock | USD 0.74 0.10 15.62% |
The company retains a Market Volatility (i.e., Beta) of 1.52, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Histogen will likely underperform. Histogen right now retains a risk of 0.0%. Please check out Histogen value at risk, as well as the relationship between the skewness and day median price , to decide if Histogen will be following its current trending patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Histogen has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Histogen is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 19.1 M |
Histogen |
Histogen Relative Risk vs. Return Landscape
If you would invest 74.00 in Histogen on January 20, 2024 and sell it today you would earn a total of 0.00 from holding Histogen or generate 0.0% return on investment over 90 days. Histogen is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Histogen, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Histogen Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Histogen's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Histogen, and traders can use it to determine the average amount a Histogen's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| HSTO |
Based on monthly moving average Histogen is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Histogen by adding Histogen to a well-diversified portfolio.
Histogen Fundamentals Growth
Histogen Stock prices reflect investors' perceptions of the future prospects and financial health of Histogen, and Histogen fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Histogen Stock performance.
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.44 | ||||
| Operating Margin | (638.32) % | ||||
| Current Valuation | (826.49 K) | ||||
| Shares Outstanding | 4.27 M | ||||
| Price To Book | 0.25 X | ||||
| Price To Sales | 1.11 X | ||||
| Revenue | 3.77 M | ||||
| EBITDA | (10.64 M) | ||||
| Cash And Equivalents | 12.6 M | ||||
| Cash Per Share | 5.04 X | ||||
| Total Debt | 4.62 M | ||||
| Debt To Equity | 0.31 % | ||||
| Book Value Per Share | 2.18 X | ||||
| Cash Flow From Operations | (9.68 M) | ||||
| Earnings Per Share | (3.79) X | ||||
| Total Asset | 19.07 M | ||||
| Retained Earnings | (88.27 M) | ||||
About Histogen Performance
To evaluate Histogen Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Histogen generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Histogen Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Histogen market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Histogen's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Histogen Inc., a clinical-stage therapeutics company, focuses on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California. Histogen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 22 people.Things to note about Histogen performance evaluation
Checking the ongoing alerts about Histogen for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Histogen help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Histogen is not yet fully synchronised with the market data | |
| Histogen has some characteristics of a very speculative penny stock | |
| Histogen has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 3.77 M. Net Loss for the year was (10.64 M) with loss before overhead, payroll, taxes, and interest of (1.25 M). | |
| Histogen currently holds about 12.6 M in cash with (9.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Histogen's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Histogen's stock is overvalued or undervalued compared to its peers.
- Examining Histogen's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Histogen's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Histogen's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Histogen's stock. These opinions can provide insight into Histogen's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Consideration for investing in Histogen Stock
If you are still planning to invest in Histogen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogen's history and understand the potential risks before investing.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |